Vicore Pharma Holding AB VICO
News
Vicore Announces Additional Subscription Undertaking from HealthCap
Vicore Initiates the Global, Randomized Phase 2b ASPIRE Trial Evaluating the Disease-Modifying Potential of Buloxibutid in Idiopathic Pulmonary Fibrosis
Vicore Announces Presentations at the European Respiratory Society Congress 2024
Interim Report April-June 2024